Sage Therapeutics
SAGE
#7472
Rank
โ‚ฌ0.27 B
Marketcap
4,51ย โ‚ฌ
Share price
-6.27%
Change (1 day)
-75.03%
Change (1 year)

Revenue for Sage Therapeutics (SAGE)

Revenue in 2024 (TTM): โ‚ฌ96.55 Million

According to Sage Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.10 Billion. In 2023 the company made a revenue of โ‚ฌ78.2 Million an increase over the revenue in the year 2022 that were of โ‚ฌ7.16 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sage Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ96.55 M23.45%
2023 โ‚ฌ78.2 M991.35%
2022 โ‚ฌ7.16 M28.66%
2021 โ‚ฌ5.56 M-99.39%
2020 โ‚ฌ0.90 B14675.38%
2019 โ‚ฌ6.13 M-92.23%
2018 โ‚ฌ78.91 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.24 B 142.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.43 B 3,325.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ0.29 B 198.58%๐Ÿ‡บ๐Ÿ‡ธ USA